Target intelligence / Profile preview

NADH:ubiquinone oxidoreductase subunit B4 pseudogene 2 (NDUFB4P2)

Target
NDUFB4P2
Molecular classification
Other, Pseudogene
01

Overview

NDUFB4P2, or NADH:ubiquinone oxidoreductase subunit B4 pseudogene 2, is classified as a **pseudogene** in the human genome and does not encode a functional protein[1]. It is related in sequence to the protein-coding gene NDUFB4, which is an accessory subunit of Complex I (NADH:ubiquinone oxidoreductase) in the mitochondrial respiratory chain[3][4][7]. However, as a pseudogene, NDUFB4P2 is not involved in the assembly or function of this enzyme complex, nor is it known to be associated with any biological activity, physiological or disease role, or to be a therapeutic target[1]. No drugs or biomarkers are linked to this pseudogene, and it is not considered relevant in clinical or pharmacological contexts. **Context and supporting details:** - The NDUFB4 gene encodes a genuine mitochondrial protein subunit; by contrast, NDUFB4P2 is a non-coding pseudogene[1]. - Pseudogenes typically do not produce functional proteins and are generally not considered druggable targets or involved in recognized biological pathways. - There is no evidence that NDUFB4P2 has a role in disease or can be used in patient selection, safety monitoring, or as a biomarker. - The only established information is its genomic, non-functional status, and not the properties used to describe drugs or receptors.

Other names
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 4, 15kDa pseudogene 2NDUFB4P2

Beyond the preview

Go deeper on NADH:ubiquinone oxidoreductase subunit B4 pseudogene 2 (NDUFB4P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NADH:ubiquinone oxidoreductase subunit B4 pseudogene 2 (NDUFB4P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call